Group items tagged

Is Spanish Easy To Learn? Yes, This is An Easy Way To Learn Spanish and The Fastest Way To Learn Spanish. Get Here about How To Learn Spanish Quick

The flu is an acute infectious disease of viral etiology. Flu symptoms are fever, cough, headache and muscle aches. It spreads easily from person to person, it circulates around the world and can affect everyone - from the youngest to the elderly and cause epidemics and pandemics. Disease known since ancient times. There is evidence that humanity has experienced so far over 30 flu pandemics, and only in the last century, there were three. The most serious of these, so called. "Spanish flu", founded in 1918, has led to the deaths of 20-50 million people. The flu virus belongs to the family Orthomyxoviridae, that there is only one race - Influenzavirus, including viruses causing disease in humans, mammals and birds. Some flu strains are species specific (infect only certain species, or only the people), but there are strains of flu that can spread from animal species to humans. Famous 3 types of flu virus - type A, type B and C. Influenza type C viruses, although similar in morphology differs from the other two types of the antigen and other basic properties. Influenza C occurs sporadically and causes respiratory disease with a slight leakage. Viruses that cause seasonal epidemics are of type A and type B. The most volatile are type A flu virus

It was of great use,when i used a 256 MB RAM.When other well-known browsers were very slow to open even two pages,K-Meleon could easily open 5 TABS simultaneously.It is a open-source software available in English,German,polish,Spanish,French and Russian.

Influenza, also known as the flu, is an infectious disease that is caused by the RN viruses, from the influenza virus's family. Fever, sore throat, chills, muscle pain, tiredness and general discomfort are among the most common symptoms of this infection. This disease may be fatal, especially for the young. There are various types of influenza and are grouped according to their genera.

Drugmaker Viatris said on Sunday (October 1) it had reached agreements to divest some of its businesses for a total of about £2.9 billion. Viatris said its move to divest some of its businesses is part of its long-term strategy to streamline focus on three core therapeutic areas - ophthalmology, gastroenterology and dermatology. The company has received an offer of about $2.17 billion (£1.78 billion) for almost all of its over-the-counter drug business from France-based Cooper Consumer Health. Viatris will retain rights for erectile dysfunction drug Viagra, nasal spray Dymista and select OTC drugs within certain markets. Separately, the drugmaker said it has agreed to sell its women's healthcare business to Spanish pharmaceutical company Insud Pharma, while its active pharmaceutical ingredients business in India will be sold to Iquest Enterprises. Both divestitures would result in about $1.2 billion (£987 million) in proceeds.

Maxwellia has appointed Ian Adamson as strategic advisor to shape the next phase of pharmacy medicine launches - a process which involves identifying and converting suitable prescription only medicines into versions people can choose to buy under the supervision of a pharmacist. Ian brings over 30 years' international consumer health and personal care experience to the Maxwellia team. He is currently an advisor to the board of the UK independent pharmacy chain Day Lewis plc, an advisor to the board of Spanish healthcare company ReVa Europe S.L and board advisor to East Midlands Pharmaceuticals Ltd. Prior to this Ian was Chief Commercial Officer and a main board director at SSL International plc (prior to its sale to Reckitt Benckiser) with responsibility for a $1bn portfolio of brands, which included Durex and Scholl. Ian's appointment follows the landmark reclassification of the progestogen only pill by the MHRA, a change spearheaded by Maxwellia, and the company's subsequent launch of its first product Lovima in July 2021; and the current MHRA public consultation on the reclassification of Maxwellia's new pharmacy brand, Aquiette 2.5mg Tablets (Oxybutynin Hydrochloride) for the treatment of overactive bladder symptoms which are not adequately controlled by bladder training alone.

When Ignasi Biosca-Reig heard there were shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production of the popular antibiotic. But a few extra shifts was as far as he could go. Much as he would have liked to significantly increase supplies, Biosca-Reig said he couldn't justify investing millions of euros in new production lines unless he was paid more for the generic drug to cover sharply rising costs. But, like many other European countries, Spain set the price manufacturers are paid for paediatric amoxicillin when the generic version of the drug was first launched in the country two decades ago, and it has barely budged since. "It's a non-business," said Biosca-Reig, chief executive of Spanish drugmaker Reig Jofre. "We wanted to react, but we had a problem," he said. "The costs go up, the price remains the same."